Reuters Health Report

Click to View in Browser 03/21/2014 Biogen Idec wins Canadian approval for hemophilia drug Alprolix (Reuters) - Biogen Idec Inc said on Friday it had won Canadian approval for its long-lasting hemophilia B drug Alprolix. Novartis loss-making vaccines division gets British boost ZURICH (Reuters) - The turnaround prospects for Novartis' loss-making vaccines division were given a boost on Friday as a key committee recommended including the Swiss drugmaker's meningitis B vaccine on Britain's routine vaccination program. EU backs J&J hepatitis C pill plus new drugs from Lilly, Takeda LONDON (Reuters) - European regulators have recommended approval of a new pill for hepatitis C from Johnson & Johnson, underscoring the rapid development of oral treatment options for the liver-destroying disease. Endocyte's drug meets goal in lung cancer study, shares soar (Reuters) - Endocyte Inc said its experimental drug improved survival rates in lung cancer patients without the disease worsening, when used in combination with an approved treatment. InterMune shares jump as Boehringer's rival drug shows mixed results BANGALORE (Reuters) - Shares of InterMune Inc rose as much as 17 percent on Friday after data showed German drugmaker Boehringer Ingleheim's rival drug had mixed results in late-stage trials. China probes schools over unauthorized medicine for toddlers BEIJING (Reuters) - China has launched a nationwide inspection of schools amid rising public anger at revelations that many educational institutions secretly gave children medicine to ward off illnesses and boost attendance, state media said on Friday. AB Science loses appeal over EU rejection of cancer drug LONDON (Reuters) - French biotech company AB Science has lost an appeal to get the London-based European Medicines Agency to reconsider its rejection of the company's cancer drug Masican, originally handed down in November. Louisiana bans components for synthetic marijuana due to health scare (Reuters) - Louisiana has banned the sale and use of eight compounds marketed as synthetic marijuana to stem an increase in the use of the drugs that have sent scores of people to hospitals with dangerous reactions to toxins, officials said on Thursday. Deadly pig virus numbers rise in U.S. hog herd (Reuters) - Confirmed cases of Porcine Epidemic Diarrhea Virus increased by 296 in the week ended March 15, bringing the total number to 4,757, according to data released on Thursday by the U.S. Department of Agriculture's National Animal Health Laboratory Network (NAHLN). Alabama lawmakers approve medical marijuana measure BIRMINGHAM, Alabama (Reuters) - A medical marijuana bill unanimously passed both the Alabama House and Senate on Thursday and is headed to the desk of Gov. Robert Bentley, who has said he will sign it into law. Related Video Autonomous drones learn to fly as a flock Old batteries power new lights in Gaza The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend